高龄老人血清尿酸水平与代谢综合征的相关性分析

doi:10.3969/j.issn.1003-9198.2023.11.005

摘要/Abstract

摘要： 目的探索高龄老人血清UA水平与代谢综合征(MS)的关系。方法选取于江苏省省级机关医院健康管理中心进行体检的1013例≥80岁高龄老人进行横断面研究,评估血清UA水平及MS情况,并采用Pearson相关和Logistic回归分析血清UA水平与MS的关系。结果在1013例高龄老人中,高尿酸血症(HUA)共269例(26.6%),MS共210例(20.7%)。UA水平与年龄、BMI、TG水平和MS呈正相关,而与FPG和HDL-C呈负相关。Logistic回归分析显示,UA是MS的独立危险因素。结论在高龄老人中,UA水平与MS的发生有显著的相关性。

关键词: 老年人, 高尿酸血症, 代谢综合征

Abstract: Objective To explore the relationship of the serum uric acid(UA) level with metabolic syndrome(MS) in the elderly aged ≥80 years old. Methods A total of 1013 elderly aged ≥80 years old from the Health Management Center of Jiangsu Provincial Geriatric Hospital were enrolled in this study.The serum level of UA was detected, and the MS were evaluated. Pearson correlation and Logistic regression were used to explore the relationship of serum UA level with MS. Results Among 1013 elderly aged≥80 years old, there were 269 (26.6%) cases of hyperuricemia, 210(20.7%) cases of MS. The level of serum UA was positively correlated with age, body mass index, triglycerides and MS, while negatively correlated with fasting plasma glucose and high-density lipoprotein cholesterol. High level of UA was an independent risk factor for MS. Conclusions In the elderly aged ≥80 years old, the level of UA is independently related to MS.

Key words: aged, hyperuricemia, metabolic syndrome

中图分类号:

R 589

郑卉, 王惠, 尹红丽, 尹冬华, 程阳, 王颖. 高龄老人血清尿酸水平与代谢综合征的相关性分析[J]. 实用老年医学, 2023, 37(11): 1099-1102.

ZHENG Hui, WANG Hui, YIN Hong-li, YIN Dong-hua, CHENG Yang, WANG Ying. Correlation of serum uric acid level with metabolic syndrome in elderly aged≥80 years old[J]. Practical Geriatrics, 2023, 37(11): 1099-1102.

参考文献

[1] DALBETH N, MERRIMAN T R, STAMP L K. Gout[J]. Lancet, 2016,388(10055):2039-2052.
[2] FU SH,YAO Y,ZHAO Y, et al. Relationships of hyperhomocysteinemia and hyperuricemia with metabolic syndrome and renal function in Chinese centenarians[J].Front Endocrinol :Lausanne, 2018, 9: 502.
[3] CHEN X M,YOKOSE C,RAI S K, et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The National Health and Nutrition Examination Survey, 2007-2016[J].Arthritis Rheumatol, 2019, 71(6): 991-999.
[4] EVERT J, LAWLER E, BOGAN H, et al. Morbidity profiles of centenarians: survivors, delayers, and escapers[J].J Gerontol A Biol Sci Med Sci, 2003, 58(3): 232-237.
[5] QIN X H, HUO Y,XIE D, et al. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials[J].Clin Nutr, 2013, 32(5): 722-727.
[6] FOROUHI N G, SATTAR N.CVD risk factors and ethnicity-a homogeneous relationship?[J].Atheroscler Suppl, 2006, 7(1): 11-19.
[7] ESTEGHAMATI A, HAFEZI-NEJAD N, ZANDIEH A, et al. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease[J]. J Cardiol, 2014, 64(4): 290-296.
[8] 中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3):156-161.
[9] MA Y C, ZUO L, CHEN J H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J].J Am Soc Nephrol, 2006, 17(10): 2937-2944.
[10] SCHULTZ A B, EDINGTON D W.Analysis of the association between metabolic syndrome and disease in a workplace population over time[J]. Value Health, 2010, 13(2):258-264.
[11] BARDIN T, RICHETTE P.Definition of hyperuricemia and gouty conditions[J]. Curr Opin Rheumatol, 2014, 26(2): 186-191.
[12] DESIDERI G, CASTALDO G, LOMBARDI A, et al. Is it time to revise the normal range of serum uric acid levels? [J]. Eur Rev Med Pharmacol Sci, 2014, 18(9):1295-1306.
[13] SHLIPAK M G, KATZ R, KESTENBAUM B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009, 204(1):298-303.
[14] LIU M, WANG J H, ZENG J, et al. Relationship between serum uric acid level and mild cognitive impairment in Chinese community elderly[J]. BMC Neurol, 2017, 17(1): 146.
[15] LIU R, HAN C, WU D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015: 762820.
[16] KUMAR A U A, BROWNE L D, LI X, et al. Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: a cohort study[J]. PLoS One, 2018, 13(5): e0198197.
[17] FU S H, PING P, LUO L M, et al. Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly individuals: results from a Chinese community-based study[J]. Clin Interv Aging, 2016, 11: 1531-1538.
[18] FORD E S, GILES W H, DIETZ W H.Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287(3): 356-359.
[19] VAN V J V, NUOTIO M-L, SLAGTER S N, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies[J]. BMC Endocr Disord, 2014, 14: 9.
[20] WILLCOX D C, WILLCOX B J, POON L W. Centenarian studies: important contributors to our understanding of the aging process and longevity[J]. Curr Gerontol Geriatr Res, 2010, 2010: 484529.
[21] ZHANG L, WAN Q L, ZHOU Y M, et al. Age-related and gender-stratified differences in the association between high triglyceride and risk of hyperuricemia[J]. Lipids Health Dis, 2019, 18(1): 147.
[22] AL-DAGHRI N M, AL-ATTAS OMAR S, WANI K, et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in Saudi type 2 diabetic patients[J]. Sci Rep, 2017, 7(1): 12104.
[23] ZHANG J X, ZHANG Y P, WU Q N, et al. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes[J]. Endocrine, 2015, 48(1): 135-142.
[24] NORVIK J V, STORHAUG H M, YTREHUS K, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study[J]. BMC Cardiovasc Disord, 2016, 16: 85.
[25] KERNER A, AVIZOHAR O, SELLA R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome[J]. Arterioscler Thromb Vasc Biol, 2005, 25(1): 193-197.